SPRY
ARS Pharmaceuticals, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Fund move
Fund move
−7.38%
vs ±22.2% implied · ×0.33
shaded = implied · ▲▼ = realized
ARS Pharmaceuticals, Inc.
3.37
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | RA Capital ManagementRA Capital Management | $87.0M | 11.94% | 0.00% | |
| 2 | Rubric Capital ManagementRubric | $68.4M | 9.39% | +6.76% | |
| 3 | Orbimed AdvisorsOrbimed | $66.4M | 9.11% | 0.00% | |
| 4 | Deerfield ManagementDeerfield | $60.1M | 8.25% | 0.00% | |
| 5 | BlackRockBlackRockindex-like | $42.5M | 5.84% | +5.97% | |
| 6 | Tyro Capital ManagementTyro | $35.7M | 4.90% | +50.22% | |
| 7 | Standard Life AberdeenStandard Life Aberdeen | $33.4M | 4.58% | +1.39% | |
| 8 | SR One Capital ManagementSR One | $32.1M | 4.41% | 0.00% | |
| 9 | State StreetState Streetindex-like | $29.9M | 4.10% | +2.35% | |
| 10 | Capital World InvestorsCapital World Investors | $22.1M | 3.03% | new | |
| 11 | Vanguard Capital ManagementVanguardindex-like | $20.5M | 2.81% | +0.43% | |
| 12 | Millennium ManagementMillennium | $20.2M | 2.77% | −57.86% | |
| 13 | Janney Montgomery ScottJanney Montgomery Scott | $16.5M | 2.27% | +2.38% | |
| 14 | UBS GroupUBS | $15.5M | 2.13% | −14.19% | |
| 15 | Geode Capital ManagementGeodeindex-like | $13.6M | 1.87% | +11.28% | |
| 16 | Boothbay Fund ManagementBoothbay Fund | $12.8M | 1.76% | +539.08% | |
| 17 | General American InvestorsGeneral American Investors | $9.1M | 1.25% | +55.82% | |
| 18 | Third PointThird Point | $8.0M | 1.10% | 0.00% | |
| 19 | Peregrine Capital ManagementPeregrine | $5.4M | 0.74% | new | |
| 20 | Tejara CapitalTejara Capital | $4.9M | 0.67% | +188.52% | |
| 21 | ADAR1 Capital ManagementADAR1 | $4.8M | 0.66% | −55.86% | |
| 22 | Pavaki Capital ManagementPavaki | $4.6M | 0.64% | +0.59% | |
| 23 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $4.5M | 0.62% | +11.02% | |
| 24 | Citadel AdvisorsCitadel | $4.5M | 0.62% | −69.21% | |
| 25 | Charles Schwab Investment ManagementCharles Schwabindex-like | $4.4M | 0.61% | +3.38% |
205 managers report $728.8M of ARS Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 17 of them hold 80% of it; RA Capital Management is largest at 11.94%.
No implied move.
No implied move.
Expected move
No implied move.